Llwytho...
Nivolumab‐induced sialadenitis
Nivolumab has been increasingly used for a range of malignancies, and a variety of immune‐related adverse events (irAEs) have been reported with its use. Nivolumab‐induced sialadenitis (inflammation of salivary glands) and xerostomia (dry mouth) have been reported to occur in 0.03% and 0.05% respect...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Respirol Case Rep |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley & Sons, Ltd
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5899999/ https://ncbi.nlm.nih.gov/pubmed/29686875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.322 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|